“With companies like Pfizer (NYSE:PFE) giving possible hope for an end of year vaccine and a recent gap up in IBB (Nasdaq Biotechnology ETF), now could be a good time […]
read more
The Investment Thesis For Biotech (And Especially Biopharma)
Despite biotech’s outperformance year-to-date, the authors of today’s article still see the industry as attractive – and they outline three key strategic themes driving their investment thesis for biotech (and […]
read more
This Buy-Rated Biotech With An Effective Alzheimer’s Drug Has Upside Potential Of Over 100%
After an initial analysis of clinical data back in May failed to demonstrate a statistically significant impact on the biomarkers associated with the disease, a re-analysis has found that the […]
read more
What Does “Merger Monday” Mean For Biotech?
“I believe that with the evidence of yesterday’s mergers, specifically the astoundingly well-priced purchase of Immunomedics (IMMU) by Gilead, that this is an area that should be speculated upon. Biotech’s […]
read more
Revisiting The Most Bought OTC Stock By Insiders In The Past Month
The company highlighted in today’s article – a direct-to-consumer telemedicine and wellness company – is the most bought OTC stock by insiders in the past month, including a purchase of […]
read more
Going ‘Small’ Could Help This New Biotech ETF Deliver Big Gains
“A biotech ETF coming to market in the midst of a global pandemic could prove to be a case of good timing for multiple reasons,” observes the author of today’s […]
read more
What Makes This Biotech An Attractive Investment Opportunity? An Impressive Brain Trust, A Supercomputer, The Third-Largest Biotech IPO In History – And More
Why might investors looking to get in on the next big biotech trend want to consider picking up shares of the company highlighted in today’s article? As the author explains, […]
read more
Which Of These Biotech Penny Stocks Are Worth The Under-$4 Price Of Admission?
The four penny stocks highlighted in today’s article are all biopharmaceutical/biotech companies, they can all be bought for under $4, and they all have important upcoming events. But which – […]
read more
The New Biotech SPAC On The Scene – And The Man Who Could Lead It To Massive Returns
What’s a SPAC – and why might investors looking to get in early on the next hot biotech stocks want to consider investing in one? As today’s article explains, a […]
read more
Why This Coronavirus Stock Is Better Than Other “Pure-Play Vaccine Players”
While the emerging biotech highlighted in today’s article is still in the early stages of developing a COVID-19 vaccine, the author advises that it “has significant advantages over other pure-play […]
read more